CNN: The US is getting a third coronavirus vaccine. Here’s how it’s different from the others

Vaccine experts agree that all the vaccines provide very good protection by the most important measure, which is whether they keep people from getting seriously ill.

But the differing efficacies raise the possibility that some people will see the Johnson & Johnson vaccine as second class, Sarah Christopherson, the policy advocacy director at the National Women’s Health Network, told an FDA advisory committee meeting Friday.

There are feelings “that there are first and second class vaccines, with the latter relegated to low income, rural, or otherwise marginalized communities that has the potential to exacerbate existing mistrust,” she said. “Public health authorities must address these perceptions head on.”

READ MORE

Previous
Previous

Guardian: US corporations push to roll back Trump-era tax policies they once endorsed

Next
Next

Washington Times: Johnson & Johnson one-shot coronavirus vaccine endorsed by FDA advisers